An evaluation of hydromethylthionine as a treatment option for Alzheimer’s disease-Reference-Cited by-同舟云学术

An evaluation of hydromethylthionine as a treatment option for Alzheimer’s disease

Published:2020-02-08 Issue:6 Volume:21 Page:619-627
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Hashweh Nader Nael¹,Bartochowski Zachary¹,Khoury Rita²³^ORCID,Grossberg George T.¹

Affiliation:

1. Department of Psychiatry and Behavioral Neuroscience, Saint Louis University School of Medicine, Saint Louis, MO, USA

2. Department of Psychiatry & Clinical Psychology, St. George Hospital University Medical Center, Balamand University, Faculty of Medicine, Beirut, Lebanon

3. Institute for Development, Research, Advocacy & Applied Care (IDRAAC), Beirut, Lebanon

Funder

not funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2020.1719066

Reference45 articles.

1. Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015–2060) in adults aged ≥65 years

2. Alzheimer's Disease: The Amyloid Cascade Hypothesis

3. Tau Protein Hyperphosphorylation and Aggregation in Alzheimer’s Disease and Other Tauopathies, and Possible Neuroprotective Strategies

4. Amyloid deposition as the central event in the aetiology of Alzheimer's disease

5. Tau-based therapies in neurodegeneration: opportunities and challenges

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alzheimer's Disease and Vascular Dementia, Connecting and Differentiating Features;Current Alzheimer Research;2024-07-29

2. Enhancing the valorization of pulping black liquors in production effective aerogel–carbon nanostructure as adsorbents toward cationic and ionic dyes;Scientific Reports;2024-07-02

3. Exploring Methylene Blue and Its Derivatives in Alzheimer's Treatment: A Comprehensive Review of Randomized Control Trials;Cureus;2023-10-09

4. Current and future therapeutic strategies for Alzheimer’s disease: an overview of drug development bottlenecks;Frontiers in Aging Neuroscience;2023-08-03

5. Molecular Mechanisms of the Neuroprotective Effect of Methylene Blue;Biochemistry (Moscow);2022-09